纳斯达克生物科技指数跌幅扩大至5.38%。成分股Syndax Pharmaceuticals跌21.37%，Taysha Gene跌18.25%，uniQure NV跌17.94%表现目前倒数第三。

Group 1 - Syndax Pharmaceuticals experienced a significant decline of 21.37% [1] - Taysha Gene saw a drop of 18.25% [1] - uniQure NV reported a decrease of 17.94%, ranking among the lowest performers [1] Group 2 - The latest price for Syndax Pharmaceuticals is 10.63, with a trading volume of 3.85 million [2] - Taysha Gene's latest price is 2.015, with a trading volume of 3.54 million [2] - uniQure NV's latest price is 13.080, with a trading volume of 1.73 million [2]